Earnings Feed
Start Free
|3Oct 2, 8:50 PM ET

KDev Investments AB 3

3 · Aprea Therapeutics, Inc. · Filed Oct 2, 2019

Insider Transaction Report

Form 3
Period: 2019-10-02
Aprea Therapeutics, Inc.APRE
KDev Investments AB
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (590,445 underlying)

  • Common Stock

    (indirect: See Footnote)
    844,278

  • Series A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (579,647 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (430,467 underlying)
Footnotes (3)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1

Documents

3 files